Flex Biomedical

company

About

Flex Biomedical develops treatments for orthopedic diseases and offers Flex Polymer, a synthetic polymer designed to treat osteoarthritis.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$881.66K
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Flex Biomedical, a Madison-based company founded in 2007, is developing innovative treatments for orthopedic diseases. The company's lead product, the Flex Polymer™, is a synthetic polymer designed to treat osteoarthritis, an incurable, debilitating joint disease that affects 27 million people in the United States and 100 million people worldwide.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.86M
Flex Biomedical has raised a total of $1.86M in funding over 2 rounds. Their latest funding was raised on Jun 20, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 20, 2012 Series Unknown $881.66K 1 NEW Capital Fund Detail
Aug 14, 2009 Series Unknown $0.98M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Flex Biomedical is funded by 1 investors. NEW Capital Fund are the most recent investors.
Investor Name Lead Investor Funding Round
NEW Capital Fund Yes Series Unknown